Peter Múdry

Combined Biodifferentiating and Antiangiogenic Oral Metronomic Therapy is Feasible and Effective in Relapsed Solid Tumors in Children: Single-Center Pilot Study

Jaroslav Štěrba, Dalibor Valík, Peter Múdry et al. · Oncology Research and Treatment · 2006 · 74 citations

Pharmacy, Oncology, Pharmacology +16

Case report: rapid and durable response to PDGFR targeted therapy in a child with refractory multiple infantile myofibromatosis and a heterozygous germline mutation of the PDGFRB gene

Peter Múdry, Ondřej Slabý, Jakub Neradil et al. · BMC Cancer · 2017 · 69 citations · Full text

Medicine, Oncology, Pediatrics +17

Effects of Sunitinib and Other Kinase Inhibitors on Cells Harboring a PDGFRB Mutation Associated with Infantile Myofibromatosis

Martin Šrámek, Jakub Neradil, Petra Macigova et al. · International Journal of Molecular Sciences · 2018 · 21 citations · Full text

Medicine, Oncology, Pharmacology +17

Assessment of Immune Response Following Dendritic Cell-Based Immunotherapy in Pediatric Patients With Relapsing Sarcoma

Lenka Fědorová, Peter Múdry, Kateřina Pilátová et al. · Frontiers in Oncology · 2019 · 18 citations · Full text

Medicine, Immunology, Oncology +17

Dendritic Cell-Based Immunotherapy in Advanced Sarcoma and Neuroblastoma Pediatric Patients: Anti-cancer Treatment Preceding Monocyte Harvest Impairs the Immunostimulatory and Antigen-Presenting Behavior of DCs and Manufacturing Process Outcome

Eva Hlaváčková, Kateřina Pilátová, Iveta Selingerová et al. · Frontiers in Oncology · 2019 · 17 citations · Full text

Medicine, Immunology, Oncology +17